Skip to content

Clinical trials

Phase 1/2 Lymphoma, Large-Cell, Anaplastic trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Large-Cell, Anaplastic Phase: Phase 1/2 Country / region: Italy Clear all

5 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20031
20121
20201
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fred Hutchinson Cancer Center2
Bristol-Myers Squibb1
Millennium Pharmaceuticals, Inc.1
Turning Point Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Large-Cell, Anaplastic5
Hodgkin Disease4
Burkitt Lymphoma3
Lymphoma, Extranodal NK-T-Cell3
Lymphoma, Large B-Cell, Diffuse3
Lymphoma, Non-Hodgkin3
Lymphoma, T-Cell, Peripheral3
Precursor Cell Lymphoblastic Leukemia-Lymphoma3
Recurrence3
Carcinoma, Renal Cell2

Trials

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.